Autonomous surgical robots raise complex questions about who is responsible when something goes wrong. Responsibility should be distributed across technical, clinical, institutional, and regulatory actors so that accountability is meaningful, legally enforceable, and linked to actual control over risks. Evidence-based frameworks from legal scholars and global health bodies support hybrid approaches that combine product liability, clinical negligence law, and regulatory oversight to address different failure modes. Ryan Abbott University of Surrey argues that existing liability doctrines must adapt to novel decision-making systems, while the World Health Organization emphasizes governance mechanisms that preserve human oversight and patient safety.
Ethical and legal allocation
From an ethical and legal perspective, manufacturers bear responsibility for design defects, inadequate validation, and poor data curation; rigorous testing and transparent reporting are necessary to meet standards of care. Surgeons and clinical teams retain responsibility for case selection, supervision, and intraoperative intervention when autonomous systems operate, because clinical judgment remains essential to respond to unexpected situations. Healthcare institutions are responsible for training, maintenance, and local implementation policies that determine whether a device is used appropriately. Regulators such as the U.S. Food and Drug Administration set premarket requirements and post-market surveillance expectations that create systemic accountability and can assign liabilities through approval conditions.
Practical steps to assign fault and prevent harm
Operationalizing allocation involves aligning legal doctrines to technical realities: use product liability for manufacturing and algorithmic defects, apply medical negligence where clinician supervision fails, and employ contract and procurement rules to allocate maintenance and update responsibilities to service providers. Shared responsibility mechanisms—such as mandatory incident reporting, transparent audit trails that record who made which decision and why, and legally recognized standards for acceptable autonomy—reduce ambiguity after adverse events. Cultural and territorial nuances matter: in communities with high deference to clinicians, legal systems may emphasize practitioner liability, while others may prioritize manufacturer accountability; low-resource settings face disproportionate risks from weak regulatory capacity and limited maintenance infrastructure, compounding environmental costs when devices fail.
When responsibility is clearly apportioned and backed by governance, harm can be reduced, trust restored, and incentives aligned toward safer design and equitable deployment.